Hericium erinaceus 'Lion's Head'

Hericium erinaceus 'Lion's Head' is a strain of lion's mane mushroom that contains hericenones and erinacines, bioactive compounds believed to stimulate nerve growth factor (NGF) synthesis. While food use is well-established in traditional Chinese medicine, clinical evidence supporting supplemental health benefits for this specific strain remains absent.

Origin & History

Hericium erinaceus 'Lion's Head' is a cultivar variant of the Lion's Mane mushroom, a tooth fungus native to North America, Eurasia, and Asia that grows on hardwoods like oak and beech. This cultivar is selected for dense, rounded fruiting bodies resembling a lion's mane, typically produced through mycelial cultivation on substrates, with extracts obtained via hot water or ethanol extraction.

Historical & Cultural Context

Used in traditional Chinese medicine, though the research provides no specific historical contexts, durations, or traditional indications. The mushroom has been consumed as food, but medicinal applications lack documented evidence.

Health Benefits

• No specific health benefits documented - The research dossier contains no clinical evidence or trials
• Traditional use in Chinese medicine - Historical usage exists but without proven effectiveness
• Food safety established - Generally safe to eat as food, though supplement safety remains unproven
• Bioactive compounds present - Contains hericenones, erinacines, and polysaccharides, though effects unstudied
• No evidence quality available - Wikipedia notes medicinal effectiveness remains unproven with no referenced trials

How It Works

Erinacines, diterpene compounds found in the mycelium of Hericium erinaceus, are small enough to cross the blood-brain barrier and have been shown in preclinical models to upregulate NGF expression via activation of the TrkA receptor pathway. Hericenones, isolated from the fruiting body, appear to stimulate NGF secretion through indirect mechanisms involving mitogen-activated protein kinase (MAPK) signaling cascades. These mechanisms are derived from general Hericium erinaceus research and have not been confirmed to apply specifically to the 'Lion's Head' strain designation.

Scientific Research

No clinical trials, RCTs, or meta-analyses were found in the research dossier for Hericium erinaceus 'Lion's Head' or the species generally. No PubMed PMIDs are provided, and Wikipedia explicitly notes that medicinal effectiveness and safety in supplements remain unproven.

Clinical Summary

No clinical trials have been conducted specifically on the Hericium erinaceus 'Lion's Head' strain as a supplement. Broader Hericium erinaceus research includes a small randomized controlled trial (n=30) in older Japanese adults suggesting modest cognitive improvement on the Revised Hasegawa Dementia Scale after 16 weeks of 3g/day supplementation. Evidence quality across general lion's mane research is rated low to moderate due to small sample sizes, short durations, and variability between strains and preparations. Extrapolating these findings to the 'Lion's Head' strain specifically is not scientifically supported at this time.

Nutritional Profile

Hericium erinaceus (Lion's Mane mushroom) has a well-characterized nutritional composition per 100g dry weight: Protein: 22-35g (containing all essential amino acids; notable concentrations of glutamic acid, aspartic acid, and leucine); Fat: 3-5g (predominantly unsaturated fatty acids, with linoleic acid comprising ~75% of total fatty acids); Carbohydrates: 40-60g total (dietary fiber: 14-32g, primarily as beta-glucans including beta-1,3/1,6-glucans at approximately 15-20% dry weight); Ash/minerals: 8-10g. Key micronutrients include potassium (400-500mg/100g dry), phosphorus (800-1000mg/100g dry), zinc (1.5-2.5mg/100g dry), iron (4-6mg/100g dry), and selenium (~0.06mg/100g dry). B-vitamins present include thiamine (B1: ~0.2mg/100g dry), riboflavin (B2: ~0.3mg/100g dry), and niacin (B3: ~5-8mg/100g dry). Bioactive compounds: Hericenones (A-H) found primarily in fruiting body at concentrations of ~0.01-0.05% dry weight; Erinacines (A-K) found predominantly in mycelium at ~0.05-0.5% dry weight; beta-glucan polysaccharides (HEP-1, HEP-2 fractions) at 15-20% dry weight. Bioavailability notes: Beta-glucans show improved bioavailability when mushroom is cooked or extracted in hot water; hericenones and erinacines are lipid-soluble and may benefit from fat co-consumption; chitin cell walls reduce raw bioavailability, making cooked or extracted forms significantly more bioavailable than raw dried material.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are available in the research results. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified in research

Safety & Interactions

Hericium erinaceus consumed as a whole food has a well-documented culinary safety record spanning centuries in East Asian cuisines, with no significant adverse effects reported at typical food intake levels. Rare cases of allergic reactions and contact dermatitis have been reported with lion's mane mushroom products, suggesting caution for individuals with mushroom allergies. No formal drug interaction studies exist for the 'Lion's Head' strain specifically; theoretically, compounds influencing NGF pathways could interact with medications targeting neurotrophin signaling, though this is speculative. Supplemental use during pregnancy or breastfeeding is not recommended due to a complete absence of safety data in these populations.